Compile Data Set for Download or QSAR
Report error Found 137 with Last Name = 'yashiro' and Initial = 'k'
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546008(CHEMBL4784090)
Affinity DataEC50:  2.65E+4nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546006(CHEMBL4747514)
Affinity DataEC50: >3.00E+4nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546007(CHEMBL4795261)
Affinity DataEC50:  5.60E+3nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546001(CHEMBL4776102)
Affinity DataEC50:  3.80E+3nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546005(CHEMBL4758530)
Affinity DataEC50:  1.65E+4nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546007(CHEMBL4795261)
Affinity DataEC50:  4.60E+3nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50545999(CHEMBL4778307)
Affinity DataEC50: >3.00E+4nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546009(CHEMBL4750436)
Affinity DataEC50: >3.00E+4nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546002(CHEMBL4747631)
Affinity DataEC50:  4.30E+3nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546003(CHEMBL4759642)
Affinity DataEC50:  7.70E+3nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546011(CHEMBL4741659)
Affinity DataEC50: >3.00E+4nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546006(CHEMBL4747514)
Affinity DataEC50:  2.02E+4nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546000(CHEMBL4780579)
Affinity DataEC50:  4.40E+3nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546010(CHEMBL4750599)
Affinity DataEC50: <3.60E+3nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50197060(CHEMBL1417584)
Affinity DataEC50:  5.20E+3nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546008(CHEMBL4784090)
Affinity DataEC50:  1.37E+4nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546011(CHEMBL4741659)
Affinity DataEC50:  2.24E+4nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546005(CHEMBL4758530)
Affinity DataEC50:  2.85E+4nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546004(CHEMBL4759521)
Affinity DataEC50:  6.10E+3nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546004(CHEMBL4759521)
Affinity DataEC50:  5.50E+3nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546012(CHEMBL4761929)
Affinity DataEC50:  1.31E+4nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50545999(CHEMBL4778307)
Affinity DataEC50:  9.50E+3nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546002(CHEMBL4747631)
Affinity DataEC50:  5.90E+3nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546000(CHEMBL4780579)
Affinity DataEC50:  7.50E+3nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546003(CHEMBL4759642)
Affinity DataEC50:  5.90E+3nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50545998(CHEMBL4745050)
Affinity DataEC50:  1.28E+4nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50545998(CHEMBL4745050)
Affinity DataEC50:  5.00E+3nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50197060(CHEMBL1417584)
Affinity DataEC50:  7.70E+3nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 2(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546010(CHEMBL4750599)
Affinity DataEC50: <3.10E+3nMAssay Description:Activation of human TREK1 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546001(CHEMBL4776102)
Affinity DataEC50:  6.80E+3nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetPotassium channel subfamily K member 10(Human)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50546009(CHEMBL4750436)
Affinity DataEC50: >3.00E+4nMAssay Description:Activation of human TREK2 by thallium flux mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104905(CHEMBL3597618)
Affinity DataIC50: 0.220nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104904(CHEMBL3597617)
Affinity DataIC50: 0.320nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104883(CHEMBL3597616)
Affinity DataIC50: 0.470nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104872(CHEMBL3597535)
Affinity DataIC50: 0.560nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104864(CHEMBL3597527)
Affinity DataIC50: 0.620nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104910(CHEMBL3597623)
Affinity DataIC50: 0.790nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104869(CHEMBL3597532)
Affinity DataIC50: 0.800nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 2(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104905(CHEMBL3597618)
Affinity DataIC50: 0.880nMAssay Description:Antagonist activity at human CysLT2 expressed in HEK293 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 2(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104883(CHEMBL3597616)
Affinity DataIC50: 0.890nMAssay Description:Antagonist activity at human CysLT2 expressed in HEK293 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 2(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104867(CHEMBL3597530)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at human CysLT2 expressed in HEK293 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104839(CHEMBL3597525)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104920(CHEMBL3597633)
Affinity DataIC50: 1.10nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104871(CHEMBL3597534)
Affinity DataIC50: 1.10nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 2(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104869(CHEMBL3597532)
Affinity DataIC50: 1.5nMAssay Description:Antagonist activity at human CysLT2 expressed in HEK293 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104836(CHEMBL3597522)
Affinity DataIC50: 1.5nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104911(CHEMBL3597624)
Affinity DataIC50: 1.5nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104870(CHEMBL3597533)
Affinity DataIC50: 1.60nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50104921(CHEMBL3597634)
Affinity DataIC50: 1.70nMAssay Description:Antagonist activity at human CysLT1 expressed in CHOK1 cells assessed as inhibition of LTD4-induced calcium mobilization preincubated for 30 mins pri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMed
TargetCysteinyl leukotriene receptor 1(Human)
Setsunan University

Curated by ChEMBL
LigandPNGBDBM50009073(cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carba...)
Affinity DataIC50: 1.90nMAssay Description:Antagonist activity at human CysLT1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2016
Entry Details Article
PubMedPDB3D3D Structure (crystal)
Displayed 1 to 50 (of 137 total ) | Next | Last >>
Jump to: